Clinical Trials
11 trialsNCT05776602 2026-06-02
Fast MRI
Karolinska University Hospital
Completed
NCT03152318 2026-03-04
rQNestin
Dana-Farber Cancer Institute
Phase 1 Active not recruiting
NCT07410676 2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2 Recruiting
NCT05677594 2026-01-12
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Johns Hopkins University
Active not recruiting
NCT07307157 2025-12-29
COSMO
Harvard Medical School (HMS and HSDM)
Enrolling by invitation
NCT02932280 2025-12-05
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
NCT07177482 2025-09-17
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Beijing Tiantan Hospital
Phase NA Recruiting
NCT04410133 2025-08-28
REVELATE
Blue Earth Diagnostics
Phase 3 Completed
NCT07126821 2025-08-17
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
Xiangya Hospital of Central South University
Recruiting
NCT04410367 2025-07-20
PURSUE
Blue Earth Diagnostics
Phase 2 Completed
NCT04111588 2025-06-22
Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases
Norwegian University of Science and Technology
Recruiting